Pharmacogenetic trial of a cannabinoid agonist shows reduced fasting colonic motility in patients with nonconstipated irritable bowel syndrome.
Gastroenterology 2011 Nov 141 (5): 1638-47.e1-7.
Wong Banny S, Camilleri Michael, Busciglio Irene, Carlson Paula, Szarka Lawrence A, Burton Duane, Zinsmeister Alan
- Page last reviewed:Jul 30, 2019
- Page last updated:Sep 18, 2019
- Content source: